Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fresh vs Frozen Stool for FMT in Children
NCT02423967Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Apr 2015
- Primary completion
- Mar 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fecal microbiome transplant in Clostridioides difficile infection (CDI) (2 arms), sponsored by Mayo Clinic. Primary endpoint: Clostridium difficile Eradication at 4 weeks. Started Apr 2015; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT02423967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02423967.